We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Triple Vascular Screening Reduces Mortality for Older Men

By MedImaging International staff writers
Posted on 13 Sep 2017
The results of a large screening trial have shown that the overall mortality of men aged between 65 and 74 could be reduced by 7%, by using combined Peripheral Artery Disease (PAD), hypertension, and Abdominal Aortic Aneurysm (AAA) screening, compared with no screening at all.

The goal of the randomized controlled trial was to examine the effect, and cost-effectiveness of the combined screening, compared to current cardiovascular screening of AAA disease alone. Combined screening consisted of Doppler-based ankle brachial index for PAD, and abdominal ultrasound for AAA. The primary outcome was all-cause mortality, while the secondary outcomes included cause-specific mortality, renal failure, cancer, diabetes, and other factors.

The results of the Viborg Vascular (VIVA) Trial that included 50,168 men from the center of Denmark, were published in the August 28, 2017, issue of the journal The Lancet, by researchers from the Odense University Hospital (Odense, Denmark), and Aarhus University (Aarhus, Denmark).

The results indicated that combined vascular AAA, PAD and hypertension screening resulted in an observed reduction of mortality risk in the study population without serious negative side effects. The researchers recommend that the combined screening method could be used as a good and cost-effective mortality prevention strategy for older men.

Chadi Ayoub, MBBS, and M. Hassan Murad, MD, said, "The VIVA trial presents thought-provoking findings. However, implementation of this triple screening intervention requires more proof than presented in this study. The 10 criteria developed in the 1960s by WHO13 remain a valid framework for establishing whether screening should be implemented or scarce resources should be directed at individuals with increased risk of morbidity and mortality."

Related Links:
Odense University Hospital
Aarhus University
Biopsy Software
Affirm® Contrast
New
Breast Localization System
MAMMOREP LOOP
New
Half Apron
Demi
New
Post-Processing Imaging System
DynaCAD Prostate

Channels

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.